Merger there. Looks like a lot of shares will be issued
Signal Genetics, Inc. and Miragen Therapeutics, Inc. (“miRagen”), a privately-held biopharmaceutical company, today announced that they have entered into a definitive merger agreement under which the stockholders of miRagen are currently estimated to become holders of approximately 96% of Signal’s outstanding common stock on a fully-diluted basis.
My posts are my opinion. Do not be influenced by anything you read on any message board website unless you can confirm it.